| Metabolism of Lipids in Advanced Cancer (NCT00962234) | AHS Cancer Control Alberta | 2009-10-01 |
| Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases (NCT01114958) | University of California, San Diego | 2009-09-03 |
| A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) (NCT00978250) | National Cancer Institute (NCI) | 2009-08-20 |
| A Study to Test Lung Function After Radiation Therapy (NCT01039649) | University of Iowa | 2009-06-01 |
| Staple-line Reinforcement for Prevention of Pulmonary Air Leakage (NCT00925444) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors (NCT00841191) | Centocor, Inc. | 2009-03-01 |
| Pulmonary Surgery and Protective Mechanical Ventilation (NCT00805077) | Assistance Publique - Hôpitaux de Paris | 2008-12-01 |
| Breath Test for Early Detection of Lung Cancer (NCT00639067) | Menssana Research, Inc. | 2008-06-01 |
| Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC) (NCT00657423) | Xijing Hospital | 2008-04-01 |
| Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation? (NCT00534690) | University Hospital, Bordeaux | 2007-11-01 |
| Thoracic OncoGeriatric Assessment (TOGA) Trials (NCT00591981) | University of Wisconsin, Madison | 2007-08-01 |
| Systemic, Intrapulmonary and Pleural Inflammatory Reaction in Patients Undergoing Thoracic Surgery (NCT00558350) | University Hospital, Basel, Switzerland | 2007-04-01 |
| An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed (NCT00497770) | Eli Lilly and Company | 2007-02-01 |
| Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) (NCT00413283) | Amgen | 2006-12-01 |
| Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen (NCT00316225) | Eli Lilly and Company | 2006-12-01 |
| Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis (NCT00243685) | Pierian Biosciences | 2006-09-01 |
| Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours (NCT00351962) | AHS Cancer Control Alberta | 2006-09-01 |
| Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor (NCT00356525) | Eli Lilly and Company | 2006-09-01 |
| Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors (NCT00385177) | Achieve Life Sciences | 2006-09-01 |
| "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer (NCT00338481) | Sankt Lukas Hospice | 2006-04-01 |
| Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China (NCT00482118) | National Cancer Institute (NCI) | 2006-02-06 |
| First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene (NCT00339586) | Universitair Ziekenhuis Brussel | 2006-01-01 |
| Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer (NCT00266877) | Puma Biotechnology, Inc. | 2005-12-01 |
| Specimen Banking From Patients With Lung Cancer (NCT01585675) | University of Colorado, Denver | 2005-11-03 |
| Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer (NCT00129844) | Pharmacyclics LLC. | 2005-09-01 |
| 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology (NCT00207298) | British Columbia Cancer Agency | 2005-06-01 |
| Characterization of Brain Metastases (NCT00184275) | Norwegian University of Science and Technology | 2005-05-01 |
| Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease (NCT00157196) | Merck KGaA, Darmstadt, Germany | 2005-04-01 |
| Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer (NCT00094094) | Pfizer | 2005-02-01 |
| Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. (NCT00184288) | Norwegian University of Science and Technology | 2004-11-01 |
| A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer (NCT00090701) | Pfizer | 2004-09-01 |
| Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) (NCT00174772) | Sanofi | 2004-03-01 |
| Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer (NCT00123760) | AHS Cancer Control Alberta | 2004-02-01 |
| Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy (NCT00100256) | Andarix Pharmaceuticals | 2004-01-01 |
| Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00071136) | Eli Lilly and Company | 2003-12-01 |
| Establishment of a Tumor Bank for Blood Samples (NCT01763125) | Medical University of Vienna | 2003-11-01 |
| Vaccine Treatment for Advanced Non-Small Cell Lung Cancer (NCT00073398) | NewLink Genetics Corporation | 2003-11-01 |
| Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax (NCT00826852) | Sanofi | 2003-10-01 |
| Establishment of a Tumor Bank for Tissue Samples (NCT01789229) | Medical University of Vienna | 2003-09-01 |
| A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer (NCT00050830) | Pfizer | 2003-01-01 |
| Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer (NCT00563420) | Hospital Authority, Hong Kong | 2002-11-01 |
| A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy (NCT00074854) | Pfizer | 2002-05-01 |
| Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days (NCT01413737) | Norwegian University of Science and Technology | 2002-01-01 |
| Acupuncture for Shortness of Breath in Cancer Patients (NCT00067691) | National Center for Complementary and Integrative Health (NCCIH) | 2001-11-01 |
| Docetaxel in Non Small Cell Lung Cancer (NSCLC) (NCT00258739) | Sanofi | 2001-10-01 |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver (NCT00041808) | FeRx | 2001-07-01 |
| GILT Docetaxel - Non-Small Cell Lung Cancer (NCT00174629) | Sanofi | 2001-06-01 |
| Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer) (NCT00157209) | Merck KGaA, Darmstadt, Germany | 2000-08-01 |
| A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab (NCT00001805) | National Cancer Institute (NCI) | 1999-03-01 |
| Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection (NCT02199886) | Boehringer Ingelheim | 1998-07-01 |
| Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity (NCT00178230) | University of Rochester | 1996-03-15 |
| Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer (NCT00001499) | National Cancer Institute (NCI) | 1996-03-01 |
| Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC (NCT00001450) | National Cancer Institute (NCI) | 1995-09-01 |
| DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer (NCT00339859) | National Cancer Institute (NCI) | 1995-06-02 |
| Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy (NCT00063219) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC (NCT06841874) | Nuvation Bio Inc. | |
| ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer. (NCT00051506) | Eli Lilly and Company | |
| Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer (NCT00040560) | Copharos | |
| Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) (NCT00034957) | Pfizer | |
| Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer (NCT00067548) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies (NCT00036023) | Amgen | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors (NCT00080041) | Pharmacyclics LLC. | |